Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kalipso Chalkidou

Showing results (31-40 of 150) with videos related to

Pageof 15
Sort By:
BMJ Evidence-Based Medicine|March 4, 2025
Harnessing health technology assessment in India: paving the way for sustainable healthcare solutions in developing countriesNicolás Meza, Paula Riganti, Kalipso Chalkidou
Journal of the Royal Society of Medicine|October 4, 2007
Making a decision to wait for more evidence: when the National Institute for Health and Clinical Excellence recommends a technology only in the context of researchKalipso Chalkidou, Andrew Hoy, Peter Littlejohns
Health Affairs (Project Hope)|March 12, 2009
Comparative effectiveness research: a useful toolDavid Barnett, Kalipso Chalkidou, Michael Rawlins
Health Economics, Policy, and Law|February 5, 2010
Eliminating drug price differentials across government programmes in the USAKalipso Chalkidou, Gerard F Anderson, Ruth Faden
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
A Health Economics Approach to US Value Frameworks: Serving the Needs of Decision MakingRichard Norman, Kalipso Chalkidou, Anthony J Culyer
Journal of Benefit-Cost Analysis|August 27, 2020
Valuing Protection against Health-Related Financial RisksJonathan Skinner, Kalipso Chalkidou, Dean T Jamison
Cost Effectiveness and Resource Allocation : C/E|November 21, 2018
Incorporating MCDA into HTA: challenges and potential solutions, with a focus on lower income settingsKevin Marsh, Praveen Thokala, Sitaporn Youngkong, et al.
Lancet (London, England)|January 30, 2019
On results reporting and evidentiary standards: spotlight on the Global FundRocco Friebel, Rachel Silverman, Amanda Glassman, et al.
F1000Research|January 16, 2018
Health Technology Assessment capacity development in low- and middle-income countries: Experiences from the international units of HITAP and NICESripen Tantivess, Kalipso Chalkidou, Nattha Tritasavit, et al.
F1000Research|June 16, 2018
Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?Anthony Culyer, Kalipso Chalkidou, Yot Teerawattananon, et al.
Pageof 15

Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
BMJ Evidence-Based Medicine|March 4, 2025
Harnessing health technology assessment in India: paving the way for sustainable healthcare solutions in developing countriesNicolás Meza, Paula Riganti, Kalipso Chalkidou
Journal of the Royal Society of Medicine|October 4, 2007
Making a decision to wait for more evidence: when the National Institute for Health and Clinical Excellence recommends a technology only in the context of researchKalipso Chalkidou, Andrew Hoy, Peter Littlejohns
Health Affairs (Project Hope)|March 12, 2009
Comparative effectiveness research: a useful toolDavid Barnett, Kalipso Chalkidou, Michael Rawlins
Health Economics, Policy, and Law|February 5, 2010
Eliminating drug price differentials across government programmes in the USAKalipso Chalkidou, Gerard F Anderson, Ruth Faden
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
A Health Economics Approach to US Value Frameworks: Serving the Needs of Decision MakingRichard Norman, Kalipso Chalkidou, Anthony J Culyer
Journal of Benefit-Cost Analysis|August 27, 2020
Valuing Protection against Health-Related Financial RisksJonathan Skinner, Kalipso Chalkidou, Dean T Jamison
Cost Effectiveness and Resource Allocation : C/E|November 21, 2018
Incorporating MCDA into HTA: challenges and potential solutions, with a focus on lower income settingsKevin Marsh, Praveen Thokala, Sitaporn Youngkong, et al.
Lancet (London, England)|January 30, 2019
On results reporting and evidentiary standards: spotlight on the Global FundRocco Friebel, Rachel Silverman, Amanda Glassman, et al.
F1000Research|January 16, 2018
Health Technology Assessment capacity development in low- and middle-income countries: Experiences from the international units of HITAP and NICESripen Tantivess, Kalipso Chalkidou, Nattha Tritasavit, et al.
F1000Research|June 16, 2018
Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?Anthony Culyer, Kalipso Chalkidou, Yot Teerawattananon, et al.
Pageof 15